Cytomed Therapeutics Limited (GDTC) Stock Price, Quote & News

Company Profile

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a plu...

Industry: Biotechnology

Sector: Healthcare

Phone: 65 6250 7738

Website: w2.cytomed.sg

Address:

1 Commonwealth Lane, No. 08-22, Singapore, Singapore

CindyFarley993 Oct. 29 at 4:52 PM

$GDTC developing science; AITX developing security — police now testing how AI cameras react, respond, and protect.

0 · Reply

ProfessorGamma Oct. 22 at 11:45 PM

$LC $GRAL $GDTC $PCG How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI

0 · Reply

DylanGFM Oct. 22 at 3:42 PM

$SCNX everything is popping and dropping ! SCALP THE SH OUT OF IT ALL!!! $GDTC $AIRE $BYND

0 · Reply

Trader_Tom Oct. 22 at 3:42 PM

$GDTC good grief. That drop didn't even trigger a halt.

0 · Reply

KingCornbread8853 Oct. 22 at 3:41 PM

$GDTC I need pt 5$ to get out lol ugh

0 · Reply

DylanGFM Oct. 22 at 3:39 PM

$GDTC God dang 😂😂😂

0 · Reply

_www_larval_com_ Oct. 22 at 3:37 PM

$GDTC has reverted -13% lower to 10% (~709Kv) in the last few minutes, follow for more volatility.

0 · Reply

DylanGFM Oct. 22 at 3:37 PM

$GDTC $AIRE lot of small gains with rejections.. Markets red. That's a bit understandable

0 · Reply

DylanGFM Oct. 22 at 3:36 PM

$GDTC look at all those green candles on $AIRE dang

0 · Reply

DylanGFM Oct. 22 at 3:32 PM

$GDTC now watching this

0 · Reply

CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript

Oct 2, 2025, 7:00 AM EDT - 4 weeks ago

CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia

Aug 28, 2025, 9:00 AM EDT - 2 months ago

Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition

Aug 18, 2025, 9:00 PM EDT - 2 months ago

CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program

Jul 21, 2025, 10:01 AM EDT - 3 months ago

Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies

Apr 28, 2025, 4:05 PM EDT - 6 months ago

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

Feb 6, 2025, 7:20 AM EST - 9 months ago

CytoMed Therapeutics announces Chairman's Letter to the Company's shareholders

Jan 6, 2025, 11:10 AM EST - 10 months ago

Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor

Aug 20, 2024, 7:00 AM EDT - 1 year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GOSS GOVX IMRN

Jul 17, 2024, 7:00 AM EDT - 1 year ago

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

Mar 20, 2024, 8:30 AM EDT - 1 year ago

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

Mar 18, 2024, 6:00 AM EDT - 1 year ago

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

Mar 4, 2024, 5:00 AM EST - 1 year ago

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Jan 29, 2024, 7:00 AM EST - 1 year ago

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Dec 5, 2023, 7:30 AM EST - 2 years ago

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

Nov 17, 2023, 9:21 AM EST - 2 years ago

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Nov 14, 2023, 7:47 AM EST - 2 years ago

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Oct 24, 2023, 1:00 PM EDT - 2 years ago

CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licensed iPSC-Based Technology

Sep 25, 2023, 7:00 AM EDT - 2 years ago

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

Sep 1, 2023, 8:00 PM EDT - 2 years ago

CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch

Aug 29, 2023, 9:00 AM EDT - 2 years ago

CytoMed Expands Research Collaboration into China After Entering Into MOU

Aug 20, 2023, 3:50 AM EDT - 2 years ago

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal

ARQT SMMT

Aug 17, 2023, 7:30 AM EDT - 2 years ago

CytoMed Therapeutics Limited to Present at the August 24th Virtual Investor Summit

Aug 15, 2023, 1:00 PM EDT - 2 years ago

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γD T In Vivo Persistency

Aug 1, 2023, 7:00 AM EDT - 2 years ago

Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Jul 27, 2023, 9:00 AM EDT - 2 years ago

CytoMed Therapeutics Announces U.S. Patent Granted For its Licensed, Novel CAR-Gamma Delta T Cell Technology

Jul 6, 2023, 7:00 AM EDT - 2 years ago

A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US

May 11, 2023, 9:00 AM EDT - 2 years ago

CytoMed Therapeutics to Ring Nasdaq Closing Bell

May 9, 2023, 10:07 AM EDT - 2 years ago

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology

Apr 13, 2023, 8:00 PM EDT - 2 years ago

CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering

Apr 7, 2023, 5:30 AM EDT - 2 years ago

U.S. IPO Weekly Recap: Small Deals Drive Activity In The IPO Market's Short Week

ARBB ATMU GDHG GMM ISPR KVUE MGIH

Feb 3, 2023, 5:46 PM EST - 2 years ago

IPO Update: CytoMed Therapeutics Aims For $11 Million U.S. IPO

CindyFarley993 Oct. 29 at 4:52 PM

$GDTC developing science; AITX developing security — police now testing how AI cameras react, respond, and protect.

0 · Reply

ProfessorGamma Oct. 22 at 11:45 PM

$LC $GRAL $GDTC $PCG How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI

0 · Reply

DylanGFM Oct. 22 at 3:42 PM

$SCNX everything is popping and dropping ! SCALP THE SH OUT OF IT ALL!!! $GDTC $AIRE $BYND

0 · Reply

Trader_Tom Oct. 22 at 3:42 PM

$GDTC good grief. That drop didn't even trigger a halt.

0 · Reply

KingCornbread8853 Oct. 22 at 3:41 PM

$GDTC I need pt 5$ to get out lol ugh

0 · Reply

DylanGFM Oct. 22 at 3:39 PM

$GDTC God dang 😂😂😂

0 · Reply

_www_larval_com_ Oct. 22 at 3:37 PM

$GDTC has reverted -13% lower to 10% (~709Kv) in the last few minutes, follow for more volatility.

0 · Reply

DylanGFM Oct. 22 at 3:37 PM

$GDTC $AIRE lot of small gains with rejections.. Markets red. That's a bit understandable

0 · Reply

DylanGFM Oct. 22 at 3:36 PM

$GDTC look at all those green candles on $AIRE dang

0 · Reply

DylanGFM Oct. 22 at 3:32 PM

$GDTC now watching this

0 · Reply

stoneblood Oct. 22 at 3:28 PM

$GDTC now we know who has been buying tyvm mr chairman

0 · Reply

DaBullRunner Oct. 22 at 3:15 PM

$GDTC there it goes… SCNX watching closely as this company is the only one I know trading under $1 with TWO FDA approved products 🚨🚨🚨

0 · Reply

KingCornbread8853 Oct. 22 at 2:37 PM

$GDTC

0 · Reply

TheManWhoSoldTheWorld Oct. 22 at 12:06 PM

$GDTC https://www.globenewswire.com/news-release/2025/10/22/3171038/0/en/CytoMed-Therapeutics-Chairman-Increases-Effective-Holdings-to-21-95.html

0 · Reply

stoneblood Oct. 16 at 6:10 PM

$GDTC these guys generate stem cells... stem cells are used in IVF possible sleeper sympathy play w/ the white house expanding access to IVF? might be nothing, could be something, im already positioned so idgaf stock trades thin

0 · Reply

Daily1515 Oct. 14 at 9:45 PM

$NVTS $ITP $INV $OMEX $GDTC

0 · Reply

StocktwitsNews Oct. 14 at 3:14 PM

Why Did CytoMed Therapeutics Stock Jump 19% Today? $GDTC https://stocktwits.com/news/equity/markets/why-did-cytomed-therapeutics-stock-jump-today/ch6mtS1R3ms

0 · Reply

DaBullRunner Oct. 14 at 1:28 PM

$ABAT stop ignoring my table pounds Because yo jade missing out on LIFE CHANGING opportunities COCH is my next one 🚨🚨🚨 Shouldn’t be under $1 or $2 And that’s being very conservative $EDHL $SSKN $GDTC $AQMS what a morning

0 · Reply

Nova_Trades Oct. 14 at 1:19 PM

$GDTC looking thin — could be gearing up for a clean breakout soon. Keep it on your radar 👀

0 · Reply

ShadowOfHELL Oct. 14 at 12:47 PM

$GDTC go for double digit

0 · Reply

KingCornbread8853 Oct. 14 at 12:31 PM

$GDTC

0 · Reply

Stock_Catcher Oct. 14 at 12:26 PM

$GDTC thin

0 · Reply

Market Cap	23.85M
Revenue (ttm)	50,000.00
Net Income (ttm)	-1.84M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3,680.00%
Debt to Equity Ratio	0.06

Volume	10,200
Avg Vol	90,268
Day's Range	N/A - N/A
Shares Out	10.94M
Stochastic %K	1%
Beta	-0.38
Analysts	Strong Buy
Price Target	$5.00